CONNETTIVINA 10GARZE 2MG 10X10

CONNETTIVINA

active ingredients

CONNETTIVINA 2mg/ml Skin spray, solution: 1 ml contains 2 mg of Hyaluronic Acid Sodium Salt. Excipients with known effects: methyl p–hydroxybenzoate and propyl p–hydroxybenzoate. CONNETTIVINA 2 mg Garze impregnated: a gauze 10x10 cm is impregnated with 4 g cream containing 2 mg of hyaluronic acid sodium salt. CONNETTIVINA 4 mg Garze impregnated: a gauze 10x20 cm is impregnated with 8 g cream containing 4 mg of hyaluronic acid sodium salt. CONNETTIVINA 12 mg Garze impregnated: a gauze 20x30 cm is impregnated with 24 g cream containing 12 mg of hyaluronic acid salt sodium excipient with known effects: polyethyleneglycol 4000. For the full list of excipients, see paragraph 6.1

Excellent

CONNETTIVINA 2 mg/ml Skin spray, Sodium chloride solution - methyl p–hydroxybenzoate - propile p–hydroxybenzoate - purified water CONNETTIVINA 2 mg Garze impregnated, CONNETTIVINA 4 mg Garze impregnated, CONNETTIVINA 12 mg Garze impregnated Glicerol – polyethyleneglycol 4000 – purified water

Therapeutic indications

Treatment of abrasions, escoriations, superficial wounds, burns, mild burns and breast ragades. Treatment of localized skin irritations, determined by physical agents such as sun, cold, wind, diaper redness, irritation and dehydration resulting from radiation treatments. Coadjuvant treatment of vascular ulcers and slow healing wounds such as decubitate wounds.

Contraindications

Hypersensitivity to the active ingredient and other substances closely related to the chemical or any of the excipients listed in the paragraph 6.1.

Population

CONNETTIVINA 2 mg/ml skin spray, solution: 2–3 applications per day, evenly covering the entire area concerned. CONNETTIVINA 2 mg Garze impregnated, CONNETTIVINA 4 mg Garze impregnated and CONNETTIVINA 12 mg Garze impregnated: apply 1 or more impregnated garzes depending on the extension of the area to be treated, changing it 2–3 times a day. If necessary cover the dressing with appropriate bandage. Before applying CONNETTIVINA spray and gauze, wounds resulting from vascular ulcers and decubitate sores should be cleaned preferably with physiological solution (NaCl 0.9%); if necessary it must be carried out surgical cleaning. Subsequently wounds must be disinfected preferably with hypopovidone or chlorhexidine. Quaternary ammonium solutions tend to precipitate hyaluronic acid and must therefore be avoided. After applying the dressing cover, possibly, with appropriate bandage.

Conservation

Cutaneous spray, solution and Garze impregnated: do not store at temperature above 30°C.

Warnings

The use of the product, especially if prolonged, can give rise to awareness phenomena. Where this happens, it is necessary to stop the treatment and establish suitable therapy.

Interactions

The association of hyaluronic acid with antibiotics and other local treatments has never given rise to phenomena of interaction. Do not simultaneously use with disinfectants containing quaternary ammonium salts as hyaluronic acid may precipitate in their presence.

Effects

Following application of CONNETTIVINA, local reactions, including allergic reactions were recorded. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address http://www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

No known cases overlapping CONNETTIVINA.

The drug can be used during pregnancy and nursing.

Source: Farmadati